In focus · trending topic

ischemic cardiomyopathy

3 stories · following the connections

CellAegis Announces First Distribution Agreement for autoRIC® in Europe

By Nasdaq OMXApr 24, 2018, 11:00 AM UTC

CellAegis Strengthens Management Team to Support Future Growth

By Nasdaq OMXApr 17, 2018, 11:00 AM UTC

CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial

By Nasdaq OMXApr 10, 2018, 11:01 AM UTC